Article

Identification of A 10-Gene Signature To Predict Efficacy of Neoadjuvant Therapy in Patients With HER2 Positive Breast Cancer.

2021-01-29

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold>Patients with human epidermal growth factor receptor 2 (HER2) positive breast cancer represent a poor prognosis, which are recommended to be treated with neoadjuvant therapy (NAT). Tumor immune microenvironment, especially tumor infiltrating cells (TILs), are proved to predict the efficacy of NAT. However, validated immune-related multi-gene signatures for HER2-p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 198ce3c3-7b14-5290-be65-956ae5124759
DOI: 10.21203/rs.3.rs-154352/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of A 10-Gene Signature To Predict Efficacy of Neoadjuvant Therapy in Patients With HER2 Positive Breast Cancer.DOI 10.21203/rs.3.rs-154352/v1Read

Identification of a 10-Gene Signature Model to Predict Efficacy of Neoadjuvant Therapy in Patients With HER2 Positive Breast Cancer.Semantic proximity Read

Identification of immune-related biomarkers for predicting neoadjuvant chemotherapy sensitivity in HER2 negative breast cancer via bioinformatics analysisSemantic proximity Read

Immune Effective Score As A Predictor Of Response To Neoadjuvant Trastuzumab Therapy And A Prognostic Indicator For HER2-positive Breast CancerSemantic proximity Read

Landscape of Immune Cell Infiltration and Inflammatory Response-related Gene Signature in Breast Cancer: an Experimental Validation StudySemantic proximity Read

Novel Immune Subtypes Identification of HER2 Positive Breast Cancer Based On Immunogenomic LandscapeSemantic proximity Read

Identification and Validation of Immune-Related Gene Prognostic Signature for breast cancerSemantic proximity Read

Identification of an immune cell infiltration-related gene signature for prognosis prediction in triple-negative breast cancer.Semantic proximity Read

A novel twelve-gene signature to evaluate neoadjuvant chemotherapy response and predict prognosis in breast cancerSemantic proximity Read

Combination of Immune-Related Network and Molecular Typing Analysis Defines a Three-Gene Signature for Predicting Prognosis of Triple-Negative Breast CancerSemantic proximity Read

Integrated immune-related gene signature predicts clinical outcome for patients with Luminal B breast cancerSemantic proximity Read